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ABSTRACT 
FOXO3a, a member of the forkhead 
homeobox type O (FOXO) family of 
transcriptional factors, regulates cell survival 
in response to DNA damage, caloric 
restriction, and oxidative stress. The von 
Hippel-Lindau (VHL) tumor suppressor gene 
encodes a component of the E3 ubiquitin 
ligase complex that mediates 
hypoxia-inducible factor-α (HIF-α) 
degradation under aerobic conditions, thus 
acting as one of the key regulators of hypoxia 
signaling. However, whether FOXO3a 
impacts cellular hypoxia stress remains 
unknown. Herein, we show that FOXO3a 
directly binds to VHL promoter and 
up-regulates VHL expression. Using a 
zebrafish model, we confirmed the 
up-regulation of vhl by foxo3b, an orthologue  
of mammalian FOXO3a. Furthermore, by 
employing the CRISPR/Cas9 technology, we 
deleted foxo3b in zebrafish and determined 
that expression of hypoxia-inducible genes 
was affected under hypoxia. Moreover, 
foxo3b-null zebrafish exhibited impaired 
acute hypoxic tolerance, resulting in death. In 
conclusion, our findings suggest that by 
modulating HIF activity via up-regulation of 
VHL, FOXO3a (foxo3b) plays an important 
role in survival in response to hypoxic stress.  
 
INTRODUCTION 
FOXO3a (also known as FKHRL1), together 
with FOXO1 (also known as FKHR), FOXO4 
(also known as AFX1) and FOXO6, comprise 
the conserved forkhead box O (FOXO) gene 
family, which is a subclass of the forkhead 
family of transcription factors. FOXO family is 
an evolutionarily conserved group of proteins 
and of vital importance in the control of cell and 
organism growth, development, metabolism, 
and longevity (1). FOXO proteins affect various 
cellular processes, including cell cycle 
regulation, cell survival, proliferation and 
apoptosis (1). In their functional capacity as 
transcription factors, FOXO proteins bind to the 
consensus sequence (5’-TTGTTTAC-3’) and 
induce expression of their down-stream targets. 
Several upstream signaling pathways modulate 
FOXO activity via nuclear-cytoplasmic shuttling 
and post-translational modifications of FOXO 
proteins (2-4).  
Multiple lines of evidence have shown that 
FOXO transcription factors are key players in 
stress signaling (1,5,6). The critical role of 
FOXO transcription factors in oxidative stress 
has been well-defined (7,8). For example, 
FOXO3a protects quiescent cells from oxidative 
stress by inducing expression of manganese 
superoxide dismutase (MnSOD) (9). Under 
oxidative stress, the function of FOXO3a is 
regulated by SIRT1 and SIRT2 deacetylation 
(10,11); FOXO3a can regulate reactive oxygen 
metabolism by inhibiting mitochondrial gene 
expression (12); association of β-catenin with 
FOXO4 or FOXO3a enhances FOXO 
transcriptional activity (13). In addition, 
redox-dependent formation of cysteine-thiol 
disulfide modulates FOXO activity (14,15). It is 
also evident that the role of FOXO family in 
oxidative stress signaling might account for 
their function in aging and cancer (16,17).  
The von Hippel-Lindau (VHL) gene is a 
classic tumor suppressor, and its inactivation is 
linked to the development of clear-cell renal cell 
carcinomas, heman-glioblastomas, 
pheochromocytomas, and tumors in other organs 
(18). The best-characterized function of pVHL 
is its ability to function as a substrate 
recognition subunit of a multi-protein E3 
ubiquitin ligase complex that targets the proline 
hydroxylated hypoxia-induced factor(HIF)-1/2α 
for proteasomal degradation under normoxic 
conditions (19) (18). Therefore, pVHL acts as a 
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key regulator in hypoxia signaling.  
Despite cellular stress induced by reactive 
oxygen, cellular oxygen is a fundamental factor 
that controls developmental processes, as well 
as normal tissue homeostasis. Oxygen is 
required for metabolism, ATP production, and 
cell survival (20,21). To maintain oxygen 
homeostasis, organisms use the hypoxia 
signaling pathway for adapting to low oxygen 
conditions (22). The hypoxia-inducible factors, 
HIF-1α and HIF-2α, coordinate the cellular 
response to hypoxic conditions by inducing 
gene expressions (23). Prolyl hydroxylase (PHD) 
gene family and pVHL E3 ligase complex 
controls HIF activity through oxygen-dependent 
hydroxylation and subsequent proteasomal 
degradation (24).  
Research has shown that 
mitochondrial-derived reactive oxygen species 
(ROS) can activate hypoxia signaling (25). 
Because FOXO3a, as well as FOXO4, can 
up-regulate MnSOD and other antioxidant 
enzymes (9,11), thus, FOXO transcription 
factors can inhibit HIF-1 activation by reducing 
the levels of mitochondrial-derived ROS, 
suggesting a connection between FOXO 
transcription factors and hypoxia signaling. 
Moreover, FOXO3a has been shown to 
up-regulate CITED2 for inhibiting 
HIF1-induced apoptosis in response to hypoxic 
stress (2) and mediates the suppressor role of 
PTEN on p300-dependent HIF-1 activity (10). 
In addition, FOXO3a has been shown to 
promote metabolic adaptation to hypoxia by 
antagonizing Myc function (18). Although these 
observations preliminarily outline the role of 
FOXO3a in hypoxia signaling, the subtle 
process and the underlying mechanisms are still 
largely unknown.  
In zebrafish, there are two orthologues of 
mammalian FOXO3 gene, foxo3a and foxo3b. 
Zebrafish foxo3b was initially identified and 
named as zFKHR/foxo5, whose protein shared 
55% identity to that of human FOXO3a (26). 
The phylogenetic analysis of vertebrate FOXO 
protein sequences showed that compared to 
foxo3a, foxo3b was much closer to mammalian 
FOXO3a (26). 
To elucidate the function of FOXO3a in 
hypoxia signaling, we examined the regulation 
of VHL by FOXO3a. In this study, we found that 
VHL was a direct down-stream target of 
FOXO3a. Using a zebrafish model, we not only 
corroborate that vhl is regulated by foxo3b, but 
also reveal that foxo3b could modulate hypoxia 
signaling through regulating vhl.  
 
RESULTS 
VHL is a direct downstream target of FOXO3a-- 
To investigate whether VHL was 
transcriptionally regulated by FOXO3a, 
promoter assays were undertaken. As shown in 
Figure 1A, luciferase reporters containing the 
full length or truncated portions of the human 
VHL promoter (-2101-+66; -989-+66; -599-+66; 
-499-+66 and -371-+66; the transcription start 
site is designated as “+1”) were transiently 
transfected into HEK293T cells together with 
Myc empty vector, or Myc tagged-FOXO3a 
expression vector. Overexpression of FOXO3a 
induced activity of  promoter reporters 
including -2101-+66; -989-+66 and -599-+66, 
but not of promoter reporters including 
-499-+66 and -371-+66 (Fig.1B). Notably, 
among three FOXO3a-inducible reporters 
(-2101-+66; -989-+66 and -599-+66), the 
reporter -599-+66 had the highest activity, 
suggesting that FOXO-DNA binding element 
(DBE) might locate in the region between -599 
to +66. After carefully searching, we identified 
one potential FOXO-DNA binding element 
(DBE) at position -567 to -561 (TTGTTAC) in 
VHL promoter (9) (Fig. 1 C). A single G to C 
substitution in the putative FOXO DBE 
completely abolished FOXO3a and 
FOXO3a-3A (an active form of FOXO3a with 
T32A/S253A/S315A triple 
mutation(2))-mediated up-regulation of the VHL 
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promoter reporter activity (Fig. 1 D).  
  To further confirm the above observations, we 
established an inducible FOXO3a-expressing 
human embryonic kidney cell line (HEK293T) 
using a lentivirus expressing a conditionally 
active FOXO3a-A3-ER fusion protein that 
consisted of a T32A/S253A/S315A triple mutant 
fused with the ligand-binding domain of the 
estrogen receptor (ER) (2,9). Expression of 
FOXO3a-A3-ER fusion protein in HEK 293T 
cells was confirmed by Western blot assays 
(Fig.1E). Treatment of the cells with 
4-hydroxy-tamoxifen (4-HT), a modified ligand 
for the ER for 16-20 h (27) significantly 
increased luciferase activity of the wildtype 
VHL promoter reporter (p<0.01), but not of the 
mutated VHL promoter reporter (Fig.1F), further 
validating the induction and binding region of 
FOXO3a on VHL promoter.  
To determine whether FOXO3a can directly 
bind to VHL promoter. We designed a pair of 
primers that could amplify a fragment 
encompassing the potential FOXO-DNA 
binding element (DBE), and performed 
chromatin immunoprecipitation (ChIP) using 
anti-FOXO3a antibody. As shown in Figure 2A 
and 2B, in vivo binding of FOXO3a to the VHL 
promoter region encompassing the FOXO DBE 
was observed. Further semi-quantitative 
RT-PCR assays validated this binding ability of 
FOXO3a (Fig. 2C).  
Subsequently, we determined the induction of 
VHL by FOXO3a in the inducible HEK293T 
cell line. After treatment of cells with 4-HT for 
24 h, a 5-fold increase in VHL mRNA was 
observed (Fig. 2D). The induction of pVHL 
protein by activating FOXO3a was further 
verified (Fig.2E). 
To determine the effect of endogenous 
FOXO3a on VHL expression. We used two sets 
of FOXO3a shRNA to knock down endogenous 
FOXO3a via lentivirus infection. Firstly, we 
confirmed the efficiency of shRNA mediated 
FOXO3a knockdown via semi-quantitative 
RT-PCR assays in HEK293T cells and H1299 
cells, respectively (Fig.3A and 3C). By contrast, 
knockdown of FOXO3a reduced VHL mRNA 
level in HEK293T cells and H1299 cells (Fig. 
3B and 3D). Moreover, reduction of pVHL 
protein level and enhancement of HIF-1α 
protein level when FOXO3a was knocked down 
was validated (Fig.3E and 3F). Taken Together, 
these results suggest that VHL might be a direct 
downstream target of FOXO3a.  
 
 
FOXO3a suppresses hypoxia-inducible gene 
expression via VHL--To understand the 
biological consequence of FOXO3a 
up-regulating VHL, we examined whether 
FOXO3a has impacts on VHL’s function. To 
date, the well-defined function of VHL is to 
modulate hypoxia inducible gene expression via 
mediating oxygen-dependent HIF-α proteasomal 
degradation (19). Therefore, we examined the 
effect of FOXO3a on hypoxia inducible gene 
expression. Overexpression of FOXO3a could 
inhibit expression of typical hypoxia inducible 
genes, SLC2A1 and LDHA(28), in HEK293T 
cells under normoxia (two left panels in Fig.4A 
and 4B).  
However, we noticed that under normoxia, 
the base level of hypoxia inducible genes, 
including SLC2A1 and LDHA  was very low 
due to lack of HIF-α. So, it was hard to evaluate 
the effect of FOXO3a on hypoxia inducible 
gene expression because of the low values 
detected. Of note, in some cases, it appeared that 
PHD still had partial impact on HIF-α function 
under a certain hypoxic conditions (29,30), thus, 
VHL could affect HIF-α function as well under 
this kind of hypoxic conditions. Because HIF-α 
protein was enhanced, resulted in higher 
expression level of hypoxia inducible gene, it 
became much easier to evaluate the effect on 
these gene expression(29,31), particularly for 
evaluating the suppression role. To get a clear 
picture about the role of FOXO3a on 
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hypoxia-inducible gene expression, we further 
examined the effect of FOXO3a under hypoxia. 
Similar to the tendency detected under normoxia,  
overexpression of FOXO3a also inhibited 
expression of SLC2A1 and LDHA under hypoxia 
(two right panels in Fig.4A and 4B, 
respectively). In addition, inhibitory effect of 
FOXO3a on hypoxia-inducible gene expression  
was more obvious under hypoxia compared to 
that under normoxia, which might resulted from 
higher base level of hypoxia-inducible gene 
under this kinds of hypoxic conditions. 
By contrast, knockdown of FOXO3a in 
H1299 cells resulted in up-regulation of 
SLC2A1 and LDHA under normoxia and 
hypoxia (Fig.4C and 4D). To validate whether 
the suppression of FOXO3a on expression of 
hypoxia-inducible genes is mediated by VHL, 
we knocked down VHL by shRNA(32) and then 
conducted further assays (Fig. 4E). Figure 4F  
shows that when VHL was knocked down, the 
inhibitory role of FOXO3a on SLC2A1 
expression was abrogated under normoxia. 
Moreover, knockdown of VHL also abolished 
the inhibitory role of FOXO3a on SLC2A1 
expression under hypoxia (Fig.4G), further 
indicating that under the hypoxic condition of 
our experiments in this study, VHL still had 
some impacts on HIF-α function. These data 
suggest that FOXO3a might modulate hypoxia 
signaling via regulation of VHL.        
 
Zebrafish vhl is a downstream target of 
foxo3b--To further determine the regulation of 
VHL by FOXO3a and the underling biological 
consequences in vivo, we took advantage of the 
zebrafish model.  
Initially, we examined the expression patterns 
of both foxo3b mRNA and vhl mRNA in 
different organs or tissues of adult zebrafish 
(3-month old) via semi-quantitative RT-PCR 
assays. Foxo3b was highly expressed in muscle, 
then in brain, heart, and liver (Fig.5A). 
Interestingly, vhl was also highly expressed in 
muscle, then in brain, heart and liver (Fig.5B). 
The similar expression patterns between foxo3b 
and vhl suggested that these two genes might be 
functionally correlated.  
Subsequently, we conducted promoter assays 
in embryos to determine whether ectopic 
expression of foxo3b could activate vhl promoter. 
Injection of a HA-foxo3b expression vector in 
zebrafish embryos induced zebrafish vhl 
promoter reporter activity (Fig. 5C). Moreover, 
the T30A/S223A/S289A foxo3b-3A mutant 
stimulated vhl promoter reporter activity to a 
greater extent than that observed for wild-type 
foxo3b, which was similar to a mammalian 
FOXO3a-3A mutant (Fig.5D) (2). By contrast, 
vhl promoter reporter activity was not induced 
by the dominant-negative foxo3b (1-277aa) (Fig. 
5D).  
 Next, we employed whole-mount in situ 
hybridization (WISH) assays for determining 
the regulation of vhl by foxo3b. The expression 
pattern of foxo3b by WISH has been reported 
previously (26). The expression patterns of vhl 
by WISH during zebrafish embryogenesis are 
shown in Figure 6. During early embryogenesis, 
expression of vhl was ubiquitous. However in 
the later stages of embryogenesis, vhl was 
expressed specifically in the otic vesicle, 
pectoral fin, inner ear, swimming bladder, 
kidney and liver (Fig. 6). Ectopic expression of 
the zebrafish foxo3b by mRNA injection 
increased vhl expression in a dose-dependent 
manner (Fig. 7A). The induction of vhl by 
ectopic expression of foxo3b was further 
validated by semi-quantitative RT-PCR assays 
(Fig.7B). By contrast, knockdown of foxo3b 
using morpholino oligonucleotides, previously 
validated for specificity and efficiency (26), 
reduced vhl expression (Fig. 7C). Similarly, 
injection of dominant-negative foxo3b mRNA 
reduced vhl expression (Fig. 7D).  
 
Targeted disruption of foxo3b in zebrafish 
enhances hypoxia-inducible gene expression 
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and impairs zebrafish hypoxia tolerance--To 
further determine the regulation of vhl by foxo3b 
and the function of foxo3b in response to 
hypoxia, we deleted foxo3b in zebrafish via 
CRISPR/Cas9 technology. To disrupt the foxo3b 
gene in zebrafish, we designed a sgRNA 
targeting a region in exon 2 of foxo3b (Fig.8A). 
After micro-injecting the synthesized sgRNA 
and Cas9 mRNA into one-cell stage embryos, 
we initially employed HMA (Heteroduplex 
mobility assay) to examine the efficiency of 
sgRNA/Cas9-mediated foxo3b disruption in F1 
generation (Fig.8B), and then conducted 
sequencing confirmation in F1 generation. After 
screening, we obtained one mutant in foxo3b 
gene (thereafter designated as MT) (Fig.8C). 
We crossed foxo3b+/-×foxo3b+/- and obtained 
offspring with foxo3b+/+, foxo3b+/- and foxo3b-/- 
genetic background at Mendel’s ratio (1:2:1). 
From the embryonic stages to adulthood, 
foxo3b-/- homozygosity were indistinguishable 
from their wild-type siblings. Overall, no 
obvious phenotypes were observed in foxo3b-/- 
zebrafish under normal condition. 
Semi-quantitative RT-PCR analysis indicated 
that foxo3b mRNA was largely reduced in 
foxo3b-null zebrafish under either normoxia or 
hypoxia (Fig.8D), which suggested that foxo3b 
was effectively disrupted. Similarly, vhl mRNA 
was also reduced in foxo3b-null zebrafish under 
either normoxia or hypoxia, but the reduction 
rate was not as dramatic as that of foxo3b 
(Fig.8E). These data suggested that vhl was 
transactivated by foxo3b in vivo and other 
FOXO family members in zebrafish might have 
partial redundant function for inducing vhl 
expression.  
Subsequently, we examined whether some 
common hypoxia-inducible genes were affected 
following disruption of foxo3b. As shown in 
Figure 9A-9D, expression of vegf, pou5f1, pai1, 
and il11a was enhanced in foxo3b-null zebrafish 
under hypoxia (28,33). These data suggested 
that foxo3b affected expression of 
hypoxia-inducible genes. Consistently, when the 
embryos were treated with DMOG, a 
hydroxylase inhibitor (34), expression of vegf 
and pou5f1 was also enhanced in foxo3b-null 
zebrafish (Fig.9E-9F). Taken together, these 
data indicated that disruption of foxo3b in 
zebrafish enhanced expression of 
hypoxia-inducible genes; and as such, foxo3b 
could modulate hypoxia signaling. 
To determine whether the effect of foxo3b 
on hypoxia-inducible gene expression was 
indeed mediated by the regulation of vhl, we 
took advantage of vhl-null zebrafish embryos 
(35). In the wild-type sibling embryos, injection 
with foxo3b mRNA inhibited expression of four 
hypoxia-inducible genes (vegf, ldha, cited2, and 
il11a) significantly compared to those injected 
with GFP mRNA (Fig.10A-10D). By contrast, 
in vhl-null embryos, injection with foxo3b 
mRNA had no obvious effect on expression of 
the four hypoxia-inducible genes (vegf, ldha, 
cited2, and il11a) compared to those injected 
with GFP mRNA (Fig.10A-10D). Expression of 
injected foxo3b and GFP mRNA was further 
confirmed by Western blot assays (Fig.10E) and 
fluorescent stereo-microscope respectively 
(Fig.10F). These data suggested that the 
suppressive role of foxo3b on expression of 
hypoxia-inducible genes was mediated by 
up-regulation of vhl.  
To determine the biological consequence of 
foxo3b in modulating hypoxia signaling, we 
compared the acute hypoxia tolerance between 
foxo3b-null zebrafish and their wild-type 
siblings. In a 2% oxygen environmental 
condition, foxo3b-null fries (15dpf) died earlier 
than their wild-type siblings (Fig.11). Similarly, 
with adult zebrafish, in a 10% oxygen 
environmental condition, foxo3b-null adults 
(3-month old) also died earlier than their 
wild-type siblings (Supplementary video 1 and 
video 2). These data suggested that foxo3b 
potentially affected zebrafish survival via 
modulation of hypoxia signaling. 
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DISCUSSION 
Low oxygen tensions activate hypoxia signaling 
by promoting the protein stability of HIF-1α and 
HIF-2α (19,21). As the key transcriptional 
regulators of hypoxia signaling, the regulation 
of HIF-1α and HIF-2α are well documented. 
Under normoxia, prolyl hydroxylases (PHD1-3) 
use oxygen as a substrate to hydroxylate key 
proline residues of HIF-1α and HIF-2α, 
resulting in subsequent proteasomal degradation 
by pVHL E3 ubiquitin ligase complex (36-38). 
Under hypoxia, PHD activity is inhibited, 
resulting in HIF-1α and HIF-2α stabilization and 
translocation to the nucleus for activating 
down-stream genes involved in systematic and 
cellular adaptation to hypoxia (39). Therefore, 
PHDs (PHD1-3) and pVHL has been recognized 
as the major regulators for modulating hypoxia 
signaling through regulating protein stability of 
HIF-1α and HIF-2α. In fact, it is evident that 
some factors could affect hypoxia signaling via 
regulation of PHDs and pVHL (31,40-43). 
Although FOXO3a has been reported to affect 
hypoxia signaling, it has not been shown to 
directly modulate the major proteins involved in 
hypoxia signaling, including PHDs and pVHL. 
Here, we show that FOXO3a (foxo3b in 
zebrafish) transactivates pVHL (vhl in zebrafish) 
expression, resulting in suppression of hypoxia 
signaling, which provides additional evidence 
for supporting the role of FOXO3a in hypoxia 
signaling. Intriguingly, FOXO3a, together with 
other FOXO family members, exhibit tumor 
suppressive functions (17,44). It is noteworthy 
that pVHL is a well-known classic tumor 
suppressor (45). Thus, FOXO3a, and other 
related FOXO proteins, might function as tumor 
suppressors by up-regulating pVHL expression. 
Confirmation of whether pVHL is transactivated 
by other FOXO family genes will further 
expand our knowledge about the function of 
FOXO family in tumor suppression.  
 As a component of an E3 ubiquitin ligase 
complex, the targets of pVHL other than HIF-α 
have been identified (35,46-48). Notably, the 
regulation of pVHL in protein level through 
protein-protein interactions or post-translational 
modifications has been revealed, which can 
affect VHL function in mediating its targets for 
proteasomal degradation (15,31,49). However, 
the regulation of VHL at transcriptional level has 
largely remained under-reported (50). Here, we 
provide data to show the transcriptional 
regulation of VHL by FOXO3a. Future studies 
to identify additional transcription factors that 
can transactivate VHL will further our 
understanding on the regulation of VHL and the 
underlying mechanism thoroughly.  
 Even though many genes have been reported to 
affect hypoxia signaling directly or indirectly, it 
is still unclear whether these genes have any 
impact on animal hypoxic tolerance (acute 
hypoxia) or hypoxic adaptation (chronic 
hypoxia)(43). In addition, a key question 
regarding the functionality of these genes  
under animal hypoxic tolerance or hypoxic 
adaptation remains unanswered. Based on the 
studies of humans high-altitude adaptation, 
especially on Tibetan adaptation studies, 
positive directional selection is identified in HIF 
pathway and hypoxia-related genes(51). Among 
these genes, HIF-2α and PHD2 genes are 
particularly noteworthy because of the 
consistency with which they have been observed 
by different investigators and the biochemical 
evidences that show the adaptive changes of 
these two genes and their effect on HIF 
signaling (51-54). These observations further 
support the vital role of HIF pathway in hypoxic 
adaptation (51). It is likely that the genes 
affecting HIF signaling should contribute to 
hypoxic tolerance or hypoxic adaptation (51). In 
this study, we showed that disruption of foxo3b 
in zebrafish led to impaired hypoxic tolerance, 
which might also be due to the influence of 
foxo3b on HIF activity via regulation of vhl. 
However, it should be acknowledged that the 
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correlation between HIF activity and hypoxia 
tolerance or adaptation is undoubtedly 
complicated (51). The change of PHD2 allele 
resulting in loss of function has been suggested 
to account for either hypoxic adaptation or 
hypoxic sensitivity (55,56). On the other hand, 
the change of allele resulting in gain-of-function 
has also been suggested to respond to either 
hypoxic adaptation or hypoxic sensitivity 
(56,57). In this regard, predicting the 
consequence of disruption of the genes involved 
in hypoxia signaling may not be simple. Given 
that HIF-1α and HIF-2α are key factors that 
orchestrate hypoxic response, further delineation 
of the hypoxic response phenotypes of these 
genes directly or indirectly involved in HIF 
pathway in knockout and overexpression status 
will uncover animal hypoxic tolerance or 
hypoxic adaptation mechanistically.  
  Of note, mitochondrial ROS are required for 
hypoxic activation of HIFs, indicating a 
connection between two vital cellular stress 
signaling (25). FOXO3a activates MnSOD 
expression to protect cells from oxidative stress 
(8,9). In this study, we found that FOXO3a 
(foxo3b) could activate VHL (vhl) expression to 
enhance zebrafish hypoxic tolerance. Therefore, 
FOXO3a may serve as a vital factor that 
orchestrates cells in response to reactive oxygen 
stress and hypoxic stress conditions.  
 
EXPERIMENTAL PROCEDURES 
Plasmid Construction--The human VHL 
promoters were amplified by PCR and 
subcloned into the pGL3-Basic vector 
(Promega). The deletion and DBE mutants of 
the VHL promoter were obtained by PCR and 
subcloned into the pGL3-Basic vector. 
FOXO3a-A3-ER was cloned into the lentivirus 
vector, pHAGE-CMV-MCS-IZsGreen. 
FOXO3a-shRNA was cloned into the lentivirus 
vector, LentiLox3.7. FOXO3a-shRNA targeting 
sequence was 
5’-GAGCTCTTGGTGGATCATC-3’ and 
5’-GCACAGAGTTGGATGAAGT-3’. Two sets 
of VHL-shRNA targeting human VHL and 
GFP-shRNA targeting GFP have been described 
previously(32).   
   The zebrafish vhl promoter was amplified by 
PCR from zebrafish genomic  DNA  using  
the  following  primers:  F: 
5’-ATATCGGTACCGACTTGGAAGTCTCGG
AAGG-3’  and  R: 
5’-ATATCCTCGAGCGTCAAAGACAGGACA
GTTCC-3’.  The  resultant  product  was 
subcloned into the pGL3-Basic vector. 
   All plasmids were verified by sequencing. 
 
Cell line and culture conditions--HEK293T and 
H1299 cell lines were originally obtained from 
ATCC. All cell lines were cultured in DMEM 
supplemented with 10% fetal bovine serum 
(FBS). HEK293T cells that constitutively 
expressed the FOXO3a-A3-ER fusion protein 
were obtained by infecting HEK293T cells with 
a lentivirus expressing FOXO3a-A3-ER. 
 
Luciferase reporter assay--HEK293T cells were 
grown in 24-well plates and transfected with the 
indicated luciferase reporter, including 
pTK-Renilla as an internal control, using 
VigoFect reagent (Vigorous Biotech, Beijing). 
Luciferase activity was assayed 16-28 h after 
transfection using the Dual-luciferase Reporter 
Assay System (Promega). Data were 
normalized to Renilla luciferase. Data are 
reported as means + S.E.M. of three 
independent experiments performed in triplicate. 
The statistical analysis was performed using 
GraphPad Prism 5 (unpaired t-test) (GraphPad 
Software Inc.).  
 For luciferase reporter assays in zebrafish, 
embryos were injected with the indicated 
plasmids and homogenized after 8-10 hrs. 
Luciferase activity was also determined using 
the Dual-luciferase Reporter Assay System.  
 
Semi-quantitative real-time RT-PCR--Total RNA 
 at Biom
edical Library, U
CSD
 on O
ctober 30, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
                                                   FOXO3a modulates hypoxia signaling 
 9 
was extracted by Trizol reagent (Invitrogen), 
and cDNA synthesis was carried out using a 
first strand cDNA synthesis kit (Fermentas). The 
following primers were used to assess human 
VHL mRNA expression: F: 5’- 
TCAGAGATGCAGGGACACACGATG-3’ 
and R: 5’- 
ACCTGACGATGTCCAGTCTCCTGTA-3’. 
The following primers were used to assess 
human FOXO3a mRNA expression: F: 5’- 
TGCTAAGCAGGCCTCATCTC-3’ and R: 5’- 
CTTGTGTCAGTTTGAGGGTCTG-3’. The 
following primers were used to evaluate the 
internal control, 18s RNA: F: 
5’-TCAACTTCGATGGTAGTCGCCGT-3’ and 
R: 5’-TCCTTGGATGTGGTAGCCGTTCT-3’.  
The following primers were used to assess 
zebrafish genes: foxo3b-RT-F: 
TCATCTTCAAGGAGGAATGC, foxo3b-RT-R: 
GGATGGAGTTCTTCCAACCA; β-actin-RT-F: 
TACAATGAGCTCCGTGTTGC, β-actin-RT-R: 
ACATACAATGGCAGGGGTGTT; vhl-RT-F: 
GTGGGACATCCATGGATGTT, vhl-RT-R: 
CGTCAGCACAGGCAATGTGA;  
pou5f1-RT-F: 
TGAGGAAGAGGAGACTCTGA, 
pou5f1-RT-R: GACTGAACATTTTGCCATAC; 
pai1-RT-F: ATTCCAAGGTTCTCCATGGA 
pai1-RT-R: GGTTCCTCAGTAGTAATGCG; 
ldha-RT-F: CCTTCTCAAGGATCTGACCG,  
ldha-RT-R: ACACTGTAATCTTTATCCGC; 
il11a-RT-F: CCGGGTGTTTAGTACAGAGATT, 
il11a-RT-R: 
CATGGAGCTGAGAAAGAGTAGG; 
cited2-RT-F: 
GTTCCGAGACAGTATCGCTAAG, 
cited2-RT-R: 
CATCAAGACCTCCTCGTCAATAA; 
vegf-RT-F: TGCTCCTGCAAATTCACACAA, 
vegf-RT-R: 
ATCTTGGCTTTTCACATCTGCAA.  
Data are reported as means + S.E.M. of 
three independent experiments performed in 
triplicate. The statistical analysis was performed 
using GraphPad Prism 5 (unpaired t-test) 
(GraphPad Software Inc.).  
 
Chromatin immunoprecipitation--An 
anti-FOXO3a antibody was purchased from 
Epitomics. The following primers were used for 
amplifying the VHL promoter region: F: 
5’-ATAAGCGTGATGATTGGGTGTTC-3’ and 
R: 5’-CCCGAGTAGTTGGTACTGTAGGC-3’. 
The primers for amplifying β-actin and the 
procedure for ChIP were described previously 
(58). 
  
Western blot assays--The following antibodies 
were used for Western blot: Myc (9E10, Santa 
Cruz), α-tubulin (Upstate). Human pVHL 
polyclonal antibody was generated against 
synthesized peptides of pVHL (Abmart, 
Shanghai, China). The pVHL (A0377),  
FOXO3a (A0102) and HIF-1α (A6265) 
antibodies were purchased from ABclonal 
Company. The procedures for Western blot 
assays were described previously (59). The Fuji 
Film LAS4000 mini luminescent image 
analyzer was used to image the blots.  
Zebrafish embryo manipulation and 
whole-mount in situ hybridization-- Zebrafish 
(Danio rerio) strain AB was raised, maintained, 
reproduced, and staged according to standard 
protocols. The probes for foxo3b and vhl were 
amplified by PCR from cDNA pools using the 
appropriate sets of primers. The primers for 
foxo3b probe were previously described (26). 
The following primers were used for the vhl 
probe: vhl-F: 
5’-CTTTAGTCTAACTCGGTGGT-3’, and 
vhl-R: AGGCAATGTGATCTTGG-3’. The 
foxo3b antisense morpholino oligonucleotides 
(foxo3b-ATG-MO and foxo3b-sp-MO) and its 
validation were also described previously (26). 
The procedure for whole-mount in situ 
hybridization was described previously (60).  
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Generation of foxo3b-null zebrafish--Disruption 
of foxo3b in zebrafish was accomplished via 
CRISPR/Cas9 technology. Zebrafish foxo3b 
sgRNA was designed using the tools provided in 
the website (http://crispr.mit.edu). The 
zebrafish-Codon-Optimized Cas9 plasmid (61) 
was digested with XbaI, purified and transcribed 
using T7 mMessage Machine Kit (Ambion). 
pUC19-gRNA vector was used for amplifying 
sgRNA template(62). The primers for 
amplifying gRNA template are: 5’- 
GTAATACGACTCACTATAGGACAACGGCA
GCCCAAGCCGTTTTAGAGCTAGAAATAGC
-3’ and 5’- AAAAGCACCGACTCGGTGCC-3’. 
sgRNA was synthesized using Transcript Aid 
T7 High Yield Transcription Kit (Fermentas). 
Cas9 RNA and sgRNA were mixed and injected 
into embryos at one cell stage. Cas9 RNA and 
sgRNA were injected at 0.75-1.25 ng/per 
embryo and 0.075 ng/per embryo, respectively.  
After the injected embryos were incubated at 
28.5℃ for 24h, the genomic DNA was extracted 
from 20-30 embryos by heating the embryos at 
94°C for 40min in lysis solution (50mM NaOH) 
(the reaction was terminated by adding 1M 
Tris-HCl (PH=8.0)). The mutant detection was 
followed HMA (Heteroduplex mobility assay) 
as described previously (63). If the results were 
positive, the remainder embryos were raised to 
adulthood and treated as F0, which were 
backcrossed with the wild-type zebrafish for 
generating F1, which were genotyped by HMA 
initially and confirmed by sequencing of target 
sites. The F1 zebrafish harboring the mutations 
were back-crossed with the wild-type zebrafish 
to obtain F2. The F2 adult zebrafish with the 
same genotype (+/-) were inter-crossed to 
generate F3 offspring, which should contain 
wildtype (+/+), heterozygous (+/-) and 
homozygous (-/-) offspring. The primers for 
detecting mutants were: F: 
5’-TGGACATTGCCATTGATCCAG-3’ and R: 
5’-CCATGCATTCCTCCTTGAAGA-3’. 
 
Hypoxic treatments—In pilot experiments, we 
noticed that zebrafish fries were more resistant 
to hypoxic treatment than adult zebrafish as 
judged by survival time in the hypoxia chamber 
(Ruskinn INVIVO2400). Thus, we used 2% oxygen for zebrafish fries’ treatment, and used 
10% oxygen for adult zebrafish’s treatment.  
For zebrafish fries, two flasks were filled with 
250 ml water respectively. Foxo3b-null fries 
(15dpf, n=20) were put into one flask and their 
wild-type siblings (15dpf, n=20) were put in the 
second flask. Then, two flasks were put into the 
hypoxia chamber simultaneously. The oxygen 
concentration of the chamber had been adjusted 
to 2% O2 ahead of time. The dead fries were counted once an hour until the death of the last 
zebrafish with one genotype (foxo3b-/-). This 
experiment was repeated for three times. 
  For adult zebrafish experiment, the zebrafish 
were initially weighed. During pilot experiments, 
we noticed that body weight of zebrafish could 
dramatically affect zebrafish acute hypoxic 
tolerance. In order to avoid interference by body 
weight in acute hypoxia tolerance determination, 
zebrafish of similar weights were chosen for 
further experiments. Subsequently, two flasks 
were filled with 250 ml water respectively. 
Three foxo3b-null zebrafish (0.36g, 0.37g, 0.39g) 
were put into one flask, and three wild-type 
siblings (0.36g, 0.37g, 0.38g) were put into the 
second flask. Before immersion into the hypoxia 
chamber (Ruskinn INVIVO2400), the oxygen concentration in flask water was measured by an 
HQd portable Meter (HACH Company, USA). 
The oxygen concentration in foxo3b-null 
zebrafish flask was 7.10 mg/L, and the oxygen 
concentration in the wildtype sibling flask was 
7.04 mg/L. The oxygen concentration in 
hypoxia chamber had been adjusted to 10% 
ahead of time. After putting the flasks 
containing zebrafish into the hypoxia chamber, 
the behavior of zebrafish was closely monitored. 
When one genotypic zebrafish was expired, we 
took out the flasks from the chamber 
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immediately and measured the oxygen 
concentration in flask water. At that moment, the 
oxygen concentration in foxo3b-null zebrafish 
flask was 1.48 mg/L, and the oxygen 
concentration in the wild-type sibling flask was 
1.54 mg/L. 
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factor; MnSOD, manganese superoxide dismutase; PHD, prolyl hydroxylase; ROS, reactive oxygen 
species; ER, estrogen receptor; 4-HT, 4-hydroxy-tamoxifen; DBE, DNA binding element; ChIP, 
chromatin immunoprecipitation;  WISH, whole-mount in situ hybridization; HMA, heteroduplex 
mobility assay. 
 
Figure legends 
Figure 1. VHL is a direct down-stream target of FOXO3a. (A) Schematic of VHL promoter constructs. 
(B) Promoter reporter activities were measured after transiently transfection with Myc empty vector or 
Myc-FOXO3a expression vector in HEK293T cells. (C) One sub-optimal FOXO DNA binding 
element (DBE), TTGTTAC (bold and underlined), was localized to the -567 to -561 region of the 
VHL promoter. (D) Compared to the wildtype VHL promoter reporter (-599/+66), the mutant VHL 
promoter reporter (single G to C substitution in the putative FOXO DBE) was not up-regulated by 
overexpression of FOXO3a and FOXO3a-3A in HEK 293T cells. (E) Expression of FOXO3a-3A-ER 
was confirmed by Western blot assays. (F) The mutant VHL promoter reporter (single G to C 
substitution in the putative FOXO DBE) was not up-regulated by FOXO3a activation. HEK 293T 
cells that constitutively express FOXO3a-A3-ER fusion protein were transfected with the wildtype or 
mutant VHL promoter reporters in the absence or presence of 4-hydroxy-tamoxifen (4-HT, 500nM)  
 
Figure 2. FOXO3a directly regulates VHL expression. (A-C) Chromatin immunoprecipitation 
analysis confirmed that FOXO3a directly interacted with the VHL promoter region harboring the 
FOXO DBE (A,B), which was confirmed by semi-quantitative real-time RT-PCR assays (C). (D) 
Semi-quantitative real-time RT-PCR assays revealed that activation of FOXO3a with 500nm 4-HT 
caused VHL mRNA increased. (E) Induction of pVHL by FOXO3a was confirmed by Western blot 
assays. 
 
Figure 3. Knockdown of FOXO3a causes VHL expression reduced. (A) Knockdown of FOXO3a by 
two sets of FOXO3a-shRNA in HEK293T cells was confirmed by semi-quantitative real-time 
RT-PCR assays. Luciferase-shRNA was used as a control. (B) Knockdown of FOXO3a in HEK293T 
caused VHL expression reduced. (C) Knockdown of FOXO3a by two sets of FOXO3a-shRNA in 
H1299 cells was confirmed by semi-quantitative real-time RT-PCR assays. Luciferase-shRNA was 
used as a control. (D) Knockdown of FOXO3a in H1299 cells caused VHL expression reduced. (E) 
Knockdown of FOXO3a resulted in reduction of endogenous pVHL and induction of endogenous 
HIF-1α in HEK293T cells was confirmed by Western blot assays. (F) Knockdown of FOXO3a 
resulted in reduction of endogenous pVHL and induction of endogenous HIF-1α in H1299 cells was 
confirmed by Western blot assays.  
 
Figure 4. FOXO3a suppresses hypoxia-inducible gene expression via VHL. (A) Overexpression of 
FOXO3a caused SLC2A1 expression reduced in HEK293T cells under normoxia and hypoxia (2% 
O2). (B) Overexpression of FOXO3a caused LDHA expression reduced in HEK293T cells under 
normoxia and hypoxia (2% O2). (C) Knockdown of FOXO3a caused SLC2A1 expression increased 
in H1299 cells under normoxia and hypoxia (2% O2). (D) Knockdown of FOXO3a caused LDHA 
expression increased in H1299 cells under normoxia and hypoxia (2% O2). (E) Knockdown of 
endogenous VHL by transiently transfected with two sets of VHL-shRNA was confirmed by Western 
blot assays. (F) When VHL was knocked down, the suppressive effect of FOXO3a on SLC2A1 
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expression was abrogated under normoxia. (G) Knockdown of VHL abolished the suppressive effect 
of FOXO3a on SLC2A1 expression under hypoxia.  
 
Figure 5. The expression pattern of vhl in zebrafish and the effect of foxo3b on vhl promoter 
activity. (A-B) Semi-quantitative real-time RT-PCR assays demonstrated the expression pattern of 
foxo3b (A) and vhl (B) in different tissues of adult zebrafish. (C) Zebrafish vhl promoter activity was 
induced after injection of foxo3b expression vector in embryos. (D) Injection of a foxo3b-3A mutant 
induced zebrafish vhl promoter activity more dramatically (column 3 vs. column 2); vhl promoter was 
not activated after injection of a foxo3b dominant-negative mutant (dn-foxo3b, p=0.089). 
 
Figure 6. The expression pattern of vhl during zebrafish embryogenesis as detected by whole-mount 
in situ hybridization assays (WISH). (A-F) vhl was ubiquitously expressed before 10-somite stage. 
(G-I) At 25 hpf (hours post fertilization), vhl was highly expressed in head and anterior mesoderm. 
(J-M) At 48 hpf, vhl was highly expressed in otic vesicle, pectoral fin and posterior mesoderm. (N-Q) 
At 3.5 dpf (days post fertilization), vhl was highly expressed in swimming bladder, inner ear and 
kidney. (R-T) At 4.5 dpf, vhl was highly expressed in swimming bladder, liver, inner ear and kidney.     
 
Figure 7. Zebrafish foxo3b enhances vhl expression. (A) Ectopic expression of foxo3b by mRNA 
injections induced vhl expression in embryos as detected by whole-mount in situ hybridization 
(WISH). GFP mRNA was used as a control. (B) Ectopic expression of foxo3b by mRNA injections 
enhanced vhl expression in embryos as revealed by semi-quantitative real-time RT-PCR assays. GFP 
mRNA was used as a control. (C) Knockdown of foxo3b in embryos by morpholino oligonucleotides 
injection reduced vhl expression. (a) Standard morpholino oligonucleotide control (STD-MO, 8 
ng/individual embryo). (b) foxo3b translation-blocking (ATG code) morpholino oligonucleotide 
(foxo3b-ATG-MO, 8 ng/individual embryo). (c) foxo3b splicing-blocking morpholino oligonucleotide 
(foxo3b-sp-MO, 8 ng/individual embryo). (D) Injection of dominant-negative foxo3b mRNA 
(dn-foxo3b) in zebrafish embryos reduced vhl expression (b) as compared to those injected with GFP 
mRNA (a). 
 
Figure 8. Generation of foxo3b -/- zebrafish via CRISPR/Cas9 technology. (A) Targeting strategy for 
generating mutations in exon 2 of foxo3b. The sequence difference in foxo3b between the mutants and 
their wild-type siblings is indicated. (B) Verification of zebrafish foxo3b disruption by HMA. 
Genomic DNA was prepared from the mutants and their wild-type siblings respectively. (C) The 
predicted protein products of foxo3b in the mutants and their wild-type siblings. (D-E) The expression 
of foxo3b (D) or vhl (E) in the wild-type (foxo3b +/+) and foxo3b-null(foxo3b -/-) zebrafish embryos 
under normoxia and hypoxia conditions. 
 
Figure 9. Zebrafish foxo3b suppresses hypoxia-induced gene expression. (A) foxo3b-null embryos 
(foxo3b-/-) exhibit higher vegf expression compared to their wild-type siblings (foxo3b +/+) under 
normoxia and hypoxia. (B) foxo3b-null embryos (foxo3b-/-) exhibit higher pou5f1 expression 
compared to their wild-type siblings (foxo3b +/+) under normoxia and hypoxia. (C) foxo3b-null 
embryos (foxo3b-/-) exhibit higher pai1 expression compared to their wild-type siblings (foxo3b +/+) 
under normoxia and hypoxia. (D) foxo3b-null embryos (foxo3b-/-) exhibit higher il11a expression 
compared to their wild-type siblings (foxo3b +/+) under normoxia and hypoxia. (E) foxo3b-null 
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embryos (foxo3b-/-) exhibit higher vegf expression compared to their wild-type siblings (foxo3b +/+) 
with or without DMOG (100μM) treatment. (E) foxo3b-null embryos (foxo3b-/-) exhibit higher pai1 
expression compared to their wild-type siblings (foxo3b +/+) with or without DMOG (100μM) 
treatment. 
 
Figure 10. Zebrafish foxo3b suppresses hypoxia-induced gene expression through vhl. (A) Ectopic 
expression of foxo3b by mRNA injections suppressed vegf expression in the wild-type sibling 
embryos (vhl +/+), but not in vhl-null embryos (vhl -/-), as revealed by semi-quantitative real-time 
RT-PCR assays. GFP mRNA injections were used as controls. (B) Ectopic expression of foxo3b by 
mRNA injections suppressed ldha expression in the wild-type sibling embryos (vhl +/+), but not in 
vhl-null embryos (vhl -/-), as revealed by semi-quantitative real-time RT-PCR assays. GFP mRNA 
injections were used as controls. (C) Ectopic expression of foxo3b by mRNA injections suppressed 
cited2 expression in the wild-type sibling embryos (vhl +/+), but not in vhl-null embryos (vhl -/-), as 
revealed by semi-quantitative real-time RT-PCR assays. GFP mRNA injections were used as controls. 
(D) Ectopic expression of foxo3b by mRNA injections suppressed il11a expression in the wild-type 
sibling embryos (vhl +/+), but not in vhl-null embryos (vhl -/-), as revealed by semi-quantitative 
real-time RT-PCR assays. GFP mRNA injections were used as controls. (E) Expression of 
myc-tagged foxo3b mRNA injected into embryos was confirmed by Western blot assays. (F) 
expression of control GFP mRNA injected into embryos was examined under a fluorescent 
stereo-microscope (Leica M205). 
 
Figure 11. Foxo3b is required for hypoxia tolerance in zebrafish. Three groups of  foxo3b-null 
zebrafish fries (15dpf, 20 each group) and their wild-type siblings (15dpf, 20 each group) were placed 
in the hypoxia chamber (Ruskinn INVIVO2400). The oxygen concentration was adjusted to 2% O2 ahead of time. The dead fries were counted once an hour until the death of the last fry with one 
genotype (foxo3b-/-).  
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Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
 
 
 
 
 
 
 
 
 
 
 
 
 at Biom
edical Library, U
CSD
 on O
ctober 30, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
                                                   FOXO3a modulates hypoxia signaling 
 25 
Figure 7 
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Figure 8 
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Figure 9 
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Figure 10 
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Figure 11 
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